Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$156.06M
↑ 14% above average
Average (9y)
$136.75M
Historical baseline
Range
High:$245.12M
Low:$66.11M
CAGR
+10.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $156.06M | +62.1% |
| 2023 | $96.27M | -32.9% |
| 2022 | $143.42M | -20.0% |
| 2021 | $179.37M | +34.7% |
| 2020 | $133.14M | +22.2% |
| 2019 | $108.94M | -55.6% |
| 2018 | $245.12M | +80.6% |
| 2017 | $135.74M | +31.3% |
| 2016 | $103.40M | +56.4% |
| 2015 | $66.11M | - |